Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1983 Feb;49(2):105–110. doi: 10.1136/hrt.49.2.105

Beta adrenoceptor antagonists after myocardial infarction--where are we now?

D A Chamberlain
PMCID: PMC481271  PMID: 6130777

Full text

PDF
105

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alvan G., von Bahr C., Seidemann P., Sjöqvist F. High plasma concentrations of beta-receptor blocking drugs and deficient debrisoquine hydroxylation. Lancet. 1982 Feb 6;1(8267):333–333. doi: 10.1016/s0140-6736(82)91583-5. [DOI] [PubMed] [Google Scholar]
  2. Baber N. S., Evans D. W., Howitt G., Thomas M., Wilson T., Lewis J. A., Dawes P. M., Handler K., Tuson R. Multicentre post-infarction trial of propranolol in 49 hospitals in the United Kingdom, Italy, and Yugoslavia. Br Heart J. 1980 Jul;44(1):96–100. doi: 10.1136/hrt.44.1.96. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Baber N. S., Lewis J. A. Beta-blockers in the treatment of myocardial infarction. Br Med J. 1980 Jul 5;281(6232):59–59. doi: 10.1136/bmj.281.6232.59-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Barber J. M., Boyle D. M., Chaturvedi N. C., Singh N., Walsh M. J. Practolol in acute myocardial infarction. Acta Med Scand Suppl. 1976;587:213–219. doi: 10.1111/j.0954-6820.1976.tb05884.x. [DOI] [PubMed] [Google Scholar]
  5. Battler A., Karliner J. S., Higgins C. B., Slutsky R., Gilpin E. A., Froelicher V. F., Ross J., Jr The initial chest x-ray in acute myocardial infarction. Prediction of early and late mortality and survival. Circulation. 1980 May;61(5):1004–1009. doi: 10.1161/01.cir.61.5.1004. [DOI] [PubMed] [Google Scholar]
  6. Campbell W. B., Johnson A. R., Callahan K. S., Graham R. M. Anti-platelet activity of beta-adrenergic antagonists: inhibition of thromboxane synthesis and platelet aggregation in patients receiving long-term propranolol treatment. Lancet. 1981 Dec 19;2(8260-61):1382–1384. doi: 10.1016/s0140-6736(81)92800-2. [DOI] [PubMed] [Google Scholar]
  7. Grayson J., Irvine M., Parratt J. R., Cunningham J. Vasospastic elements in myocardial infarction following coronary occlusion in the dog. Cardiovasc Res. 1968 Jan;2(1):54–62. doi: 10.1093/cvr/2.1.54. [DOI] [PubMed] [Google Scholar]
  8. HAN J., GARCIADEJALON P., MOE G. K. ADRENERGIC EFFECTS ON VENTRICULAR VULNERABILITY. Circ Res. 1964 Jun;14:516–524. doi: 10.1161/01.res.14.6.516. [DOI] [PubMed] [Google Scholar]
  9. Hampton J. R. The use of beta blockers for the reduction of mortality after myocardial infarction. Eur Heart J. 1981 Aug;2(4):259–268. doi: 10.1093/oxfordjournals.eurheartj.a061206. [DOI] [PubMed] [Google Scholar]
  10. Hansteen V., Møinichen E., Lorentsen E., Andersen A., Strøm O., Søiland K., Dyrbekk D., Refsum A. M., Tromsdal A., Knudsen K. One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial. Br Med J (Clin Res Ed) 1982 Jan 16;284(6310):155–160. doi: 10.1136/bmj.284.6310.155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hjalmarson A., Elmfeldt D., Herlitz J., Holmberg S., Málek I., Nyberg G., Rydén L., Swedberg K., Vedin A., Waagstein F. Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial. Lancet. 1981 Oct 17;2(8251):823–827. doi: 10.1016/s0140-6736(81)91101-6. [DOI] [PubMed] [Google Scholar]
  12. Julian D. G., Prescott R. J., Jackson F. S., Szekely P. Controlled trial of sotalol for one year after myocardial infarction. Lancet. 1982 May 22;1(8282):1142–1147. doi: 10.1016/s0140-6736(82)92225-5. [DOI] [PubMed] [Google Scholar]
  13. Lemberg L., Castellanos A., Jr, Arcebal A. G. The use of propranolol in arrhythmias complicating acute myocardial infarction. Am Heart J. 1970 Oct;80(4):479–487. doi: 10.1016/0002-8703(70)90195-x. [DOI] [PubMed] [Google Scholar]
  14. Lewis J. A. Beta-blockade after myocardial infarction--a statistical view. Br J Clin Pharmacol. 1982;14 (Suppl 1):15S–21S. doi: 10.1111/j.1365-2125.1982.tb02055.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Maseri A., L'Abbate A., Baroldi G., Chierchia S., Marzilli M., Ballestra A. M., Severi S., Parodi O., Biagini A., Distante A. Coronary vasospasm as a possible cause of myocardial infarction. A conclusion derived from the study of "preinfarction" angina. N Engl J Med. 1978 Dec 7;299(23):1271–1277. doi: 10.1056/NEJM197812072992303. [DOI] [PubMed] [Google Scholar]
  16. May G. S., Eberlein K. A., Furberg C. D., Passamani E. R., DeMets D. L. Secondary prevention after myocardial infarction: a review of long-term trials. Prog Cardiovasc Dis. 1982 Jan-Feb;24(4):331–352. doi: 10.1016/0033-0620(82)90010-x. [DOI] [PubMed] [Google Scholar]
  17. Michelakis A. M., McAllister R. G. The effect of chronic adrenergic receptor blockade on plasma renin activity in man. J Clin Endocrinol Metab. 1972 Feb;34(2):386–394. doi: 10.1210/jcem-34-2-386. [DOI] [PubMed] [Google Scholar]
  18. Moss A. J., Davis H. T., DeCamilla J., Bayer L. W. Ventricular ectopic beats and their relation to sudden and nonsudden cardiac death after myocardial infarction. Circulation. 1979 Nov;60(5):998–1003. doi: 10.1161/01.cir.60.5.998. [DOI] [PubMed] [Google Scholar]
  19. Mueller H. S., Ayres S. M., Religa A., Evans R. G. Propranolol in the treatment of acute myocardial infarction. Effect on myocardial oxygenation and hemodynamics. Circulation. 1974 Jun;49(6):1078–1087. doi: 10.1161/01.cir.49.6.1078. [DOI] [PubMed] [Google Scholar]
  20. Newman R. J. Comparison of the antilipolytic effect of metoprolol, acebutolol, and propranolol in man. Br Med J. 1977 Sep 3;2(6087):601–603. doi: 10.1136/bmj.2.6087.601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Norris R. M., Caughey D. E., Scott P. J. Trial of propranolol in acute myocardial infarction. Br Med J. 1968 May 18;2(5602):398–400. doi: 10.1136/bmj.2.5602.398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Ramsdale D. R., Faragher E. B., Bennett D. H., Bray C. L., Ward C., Cruickshank J. M., Yusuf S., Sleight P. Ischemic pain relief in patients with acute myocardial infarction by intravenous atenolol. Am Heart J. 1982 Apr;103(4 Pt 1):459–467. doi: 10.1016/0002-8703(82)90330-1. [DOI] [PubMed] [Google Scholar]
  24. Roland J. M., Wilcox R. G., Banks D. C., Edwards B., Fentem P. H., Hampton J. R. Effect of beta-blockers on arrhythmias during six weeks after suspected myocardial infarction. Br Med J. 1979 Sep 1;2(6189):518–521. doi: 10.1136/bmj.2.6189.518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Sainte-Rose C., Roux F. X., Renier D., Pierre-Kahn A., Hirsch J. F. Abcès cérébraux des cardiopathies congénitales de l'enfant. Neurochirurgie. 1982;28(1):33–40. [PubMed] [Google Scholar]
  26. Sanz G., Castañer A., Betriu A., Magriña J., Roig E., Coll S., Paré J. C., Navarro-López F. Determinants of prognosis in survivors of myocardial infarction: a prospective clinical angiographic study. N Engl J Med. 1982 May 6;306(18):1065–1070. doi: 10.1056/NEJM198205063061801. [DOI] [PubMed] [Google Scholar]
  27. Shand D. G., Rangno R. E. The disposition of propranolol. I. Elimination during oral absorption in man. Pharmacology. 1972;7(3):159–168. doi: 10.1159/000136285. [DOI] [PubMed] [Google Scholar]
  28. Starling M. R., Crawford M. H., Kennedy G. T., O'Rourke R. A. Exercise testing early after myocardial infarction: predictive value for subsequent unstable angina and death. Am J Cardiol. 1980 Dec 1;46(6):909–914. doi: 10.1016/0002-9149(80)90344-6. [DOI] [PubMed] [Google Scholar]
  29. Théroux P., Waters D. D., Halphen C., Debaisieux J. C., Mizgala H. F. Prognostic value of exercise testing soon after myocardial infarction. N Engl J Med. 1979 Aug 16;301(7):341–345. doi: 10.1056/NEJM197908163010701. [DOI] [PubMed] [Google Scholar]
  30. Verrier R. L., Thompson P. L., Lown B. Ventricular vulnerability during sympathetic stimulation: role of heart rate and blood pressure. Cardiovasc Res. 1974 Sep;8(5):602–610. doi: 10.1093/cvr/8.5.602. [DOI] [PubMed] [Google Scholar]
  31. Waldenström A. P., Hjalmarson A. C., Thornell L. A possible role of noradrenaline in the development of myocardial infarction: an experimental study in the isolated rat heart. Am Heart J. 1978 Jan;95(1):43–51. doi: 10.1016/0002-8703(78)90395-2. [DOI] [PubMed] [Google Scholar]
  32. Weksler B. B., Gillick M., Pink J. Effect of propranolol on platelet function. Blood. 1977 Feb;49(2):185–196. [PubMed] [Google Scholar]
  33. Wilcox R. G., Roland J. M., Banks D. C., Hampton J. R., Mitchell J. R. Randomised trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction. Br Med J. 1980 Mar 29;280(6218):885–888. doi: 10.1136/bmj.280.6218.885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Wilcox R. G., Rowley J. M., Hampton J. R., Mitchell J. R., Roland J. M., Banks D. C. Randomised placebo-controlled trial comparing oxprenolol with disopyramide phosphate in immediate treatment of suspected myocardial infarction. Lancet. 1980 Oct 11;2(8198):765–769. doi: 10.1016/s0140-6736(80)90385-2. [DOI] [PubMed] [Google Scholar]
  35. Wilhelmsson C., Vedin J. A., Wilhelmsen L., Tibblin G., Werkö L. Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Preliminary results. Lancet. 1974 Nov 16;2(7890):1157–1160. doi: 10.1016/s0140-6736(74)90807-1. [DOI] [PubMed] [Google Scholar]
  36. Wolfson S., Gorlin R. Cardiovascular pharmacology of propranolol in man. Circulation. 1969 Oct;40(4):501–511. doi: 10.1161/01.cir.40.4.501. [DOI] [PubMed] [Google Scholar]
  37. Yusuf S., Ramsdale D., Peto R., Furse L., Bennett D., Bray C., Sleight P. Early intravenous atenolol treatment in suspected acute myocardial infarction. Preliminary report of a randomised trial. Lancet. 1980 Aug 9;2(8189):273–276. doi: 10.1016/s0140-6736(80)90231-7. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES